These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
540 related items for PubMed ID: 29027620
41. Sodium Zirconium Cyclosilicate (ZS-9): A Novel Agent for the Treatment of Hyperkalemia. Linder KE, Krawczynski MA, Laskey D. Pharmacotherapy; 2016 Aug; 36(8):923-33. PubMed ID: 27393581 [Abstract] [Full Text] [Related]
42. Hyperkalemia in chronic kidney disease. Watanabe R. Rev Assoc Med Bras (1992); 2020 Jan 13; 66Suppl 1(Suppl 1):s31-s36. PubMed ID: 31939533 [Abstract] [Full Text] [Related]
43. Randomized, Controlled Trial of the Effect of Dietary Potassium Restriction on Nerve Function in CKD. Arnold R, Pianta TJ, Pussell BA, Kirby A, O'Brien K, Sullivan K, Holyday M, Cormack C, Kiernan MC, Krishnan AV. Clin J Am Soc Nephrol; 2017 Oct 06; 12(10):1569-1577. PubMed ID: 28893921 [Abstract] [Full Text] [Related]
53. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? Sterns RH, Rojas M, Bernstein P, Chennupati S. J Am Soc Nephrol; 2010 May 06; 21(5):733-5. PubMed ID: 20167700 [Abstract] [Full Text] [Related]
54. Sodium zirconium cyclosilicate for the management of chronic hyperkalemia in kidney disease, a novel agent. Rastogi A, Hanna RM, Mkrttchyan A, Khalid M, Yaqoob S, Shaffer K, Dhawan P, Nobakht N, Kamgar M, Goshtaseb R, Sarmosyan K, Gnarini M, Wassef O, Lerma E. Expert Rev Clin Pharmacol; 2021 Sep 06; 14(9):1055-1064. PubMed ID: 34227913 [Abstract] [Full Text] [Related]
55. Potassium Binders for Hyperkalemia in Chronic Kidney Disease-Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis. Palmer BF. Mayo Clin Proc; 2020 Feb 06; 95(2):339-354. PubMed ID: 31668450 [Abstract] [Full Text] [Related]
56. Acute abdomen with colonic necrosis induced by Kayexalate-sorbitol. Dardik A, Moesinger RC, Efron G, Barbul A, Harrison MG. South Med J; 2000 May 06; 93(5):511-3. PubMed ID: 10832954 [Abstract] [Full Text] [Related]
57. A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient. Ash SR, Singh B, Lavin PT, Stavros F, Rasmussen HS. Kidney Int; 2015 Aug 06; 88(2):404-11. PubMed ID: 25651363 [Abstract] [Full Text] [Related]
58. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial. Bakris GL, Pitt B, Weir MR, Freeman MW, Mayo MR, Garza D, Stasiv Y, Zawadzki R, Berman L, Bushinsky DA, AMETHYST-DN Investigators. JAMA; 2015 Jul 14; 314(2):151-61. PubMed ID: 26172895 [Abstract] [Full Text] [Related]
59. Sodium Polystyrene Sulfonate and Cytomegalovirus-Associated Hemorrhagic Duodenitis: More than Meets the Eye. Gürtler N, Hirt-Minkowski P, Brunner SS, König K, Glatz K, Reichenstein D, Bassetti S, Osthoff M. Am J Case Rep; 2018 Aug 03; 19():912-916. PubMed ID: 30072684 [Abstract] [Full Text] [Related]
60. Inflammatory Pseudotumor Containing Kayexalate Crystals: A Case Report and Review of the Literature. Romano RC, Thirumala S, Cushman WH, Mounajjed T. Int J Surg Pathol; 2014 Aug 03; 22(5):464-9. PubMed ID: 24178951 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]